Psoriatic arthritis trials in Israel
7 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study of Baricitinib in Participants From 1 Year to Less Than 18 Years Old With Juvenile Idiopathic Arthritis
- Where
- Haifa, Kfar Saba, Petah Tikva, Ramat Gan
- Age
- 1 year to 18 years
- People
- 190 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT03773965 - Phase 3Taking peopleA Study of Apremilast in Children With Oral Ulcers Associated With Behçet's Disease or Juvenile Psoriatic Arthritis
- Where
- Kfar Saba
- Age
- 5 years to 18 years
- People
- 48 worldwide
- Run by
- Amgen
See details and how to joinNCT05767047 - Phase 3Taking peopleA Long-term Extension (LTE) Study of Guselkumab in Pediatric Participants
- Where
- Jerusalem
- Age
- 3 years to 64 years
- People
- 196 worldwide
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT06663332 · EU 2023-509560-16-00 - No phaseTaking peopleObservational Study of Pediatric Rheumatic Diseases: The CARRA Registry
- Where
- Petah Tikva
- Age
- Up to 21 years
- People
- 20,000 worldwide
- Run by
- Duke University
See details and how to joinNCT02418442 - Phase 3Taking peopleA Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic Medicines
- Where
- Ashdod, Ashkelon, Haifa, Nahariya, Ramat Gan, Tel Aviv
- Age
- 18 years and over
- People
- 1,088 worldwide
- Run by
- Takeda
See details and how to joinNCT06671483 · EU 2024-513111-27-00 - Phase 3Taking peopleContinuation Study of Zasocitinib in Adults With Psoriatic Arthritis
- Where
- Nahariya
- Age
- 18 years and over
- People
- 1,182 worldwide
- Run by
- Takeda
See details and how to joinNCT07286058 · EU 2025-522586-30-00 - No phaseTaking peopleAn Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
- Where
- Haifa, Jerusalem, Kfar Saba, Nahariya, Ramat Gan, Tel Aviv
- Age
- 18 years to 75 years
- People
- 1,200 worldwide
- Run by
- AbbVie
See details and how to joinNCT06764693